£114.06

This is the most expensive it has ever been. Walk away.

£114 today · previous high £114 · all-time low £108

Springer Organ Directed Toxicities of Anticancer Drugs: Proceedings of the First International Symposium on the Organ Directed Toxicities of the Anticancer ... 4–6, 1987: 53 (Developments in Oncology, 53)

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 65 days · 65 data points (no recent data)

Historical
Generating forecast…
£114.06 £107.37 £108.83 £110.29 £111.75 £113.21 £114.67 22 August 2026 07 September 2026 23 September 2026 09 October 2026 25 October 2026
View at Amazon ↗

Price data last checked 26 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 65 days • 2 price levels

Days at Price
Current Price
30 days 35 days · current 0 9 18 26 35 £108 £114 Days at Price

Price Analysis

Most common price: £114 (35 days, 53.8%)

Price range: £108 - £114

Price levels: 2 different prices over 65 days

Description

The addition of chemotherapy as an effective means to treat cancer has had a major impact on selected human malignancies. Due to a general inability to dif ferentiate between normal and neoplastic cells, little selectivity exists in currently used oncolytic drugs. Consequently, significant toxicity to the patient is expected when systemic cancer chemotherapy is chosen as an appropriate therapeutic in tervention. Much of this toxicity, such as damage to the bone marrow, gastroin testinal tract, or hair follicles, is predictable based upon the fact that anticancer drugs kill actively dividing cells. These types of toxicities, while serious, are usually manageable and reversible and are, therefore, not often considered to be dose limiting. Unfortunately, several of the most important anticancer drugs also damage tissues in which the growth fraction is relatively small. Such toxicities can not be predicted based on the chemical structure of the drugs, are often not detected in preclinical studies, and are encountered frequently for the first time in clinical studies. Further, unlike most of the proliferative-dependent toxicities, the unpre dicted toxicities are usually irreversible or only partially reversible upon cessation of drug administration. Because of this, the unpredicted toxicities are referred to as dose limiting. They represent a significant barrier to the ultimate efficacy of several of our most important anticancer drugs.

Product Specifications

Format
paperback
Domain
Amazon UK
Publication Date
24 November 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Pathobiology of Cancer Regimen-Related Toxicities
82% match

Pathobiology of Cancer Regimen-Related Toxicities

Springer

£111.56 24 Oct 2026
Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)
82% match

Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances: 42 (Cancer Treatment and Research, 42)

Springer

£107.85 24 Oct 2026
Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models
81% match

Drug Targets in Cellular Processes of Cancer: From Nonclinical to Preclinical Models

Springer

£75.96 26 Oct 2026
Cancer Drug Discovery: Science and History
80% match

Cancer Drug Discovery: Science and History

Springer

£109.80 22 Oct 2026
Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)
79% match

Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)

Springer

£105.00 24 Oct 2026
Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)
79% match

Cancer Chemotherapy 1: 7 (Cancer Treatment and Research)

Springer

£161.26 24 Oct 2026
Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide
79% match

Drug Therapy and Interactions in Pediatric Oncology: A Pocket Guide

Springer

£84.04 21 Oct 2026
New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)
79% match

New Drugs, Concepts and Results in Cancer Chemotherapy: 58 (Cancer Treatment and Research, 58)

Springer

£128.37 13 Nov 2026
Nutraceuticals and Cancer
79% match

Nutraceuticals and Cancer

Springer

£113.76 23 Oct 2026
Pharmaceutical Perspectives of Cancer Therapeutics
78% match

Pharmaceutical Perspectives of Cancer Therapeutics

Springer

£179.99 27 Oct 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
78% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£100.11 24 Oct 2026
Oncologic Therapies
78% match

Oncologic Therapies

Springer

£81.74 23 Oct 2026
Metronomic Chemotherapy: Pharmacology and Clinical Applications
78% match

Metronomic Chemotherapy: Pharmacology and Clinical Applications

Springer

£83.72 23 Oct 2026
Biology and Therapy of Acute Leukemia: Proceedings of the Seventeenth Annual Detroit Cancer Symposium Detroit, Michigan ― April 12–13, 1984: 33 (Developments in Oncology, 33)
78% match

Biology and Therapy of Acute Leukemia: Proceedings of the Seventeenth Annual Detroit Cancer Symposium Detroit, Michigan ― April 12–13, 1984: 33 (Developments in Oncology, 33)

Springer

£113.77 24 Oct 2026
Anticancer plants: Properties and Application: Volume 1
78% match

Anticancer plants: Properties and Application: Volume 1

Springer

£113.96 27 Oct 2026
Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)
78% match

Drug Resistance in Cancer Therapy: 48 (Cancer Treatment and Research, 48)

Springer

£113.76 22 Oct 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
78% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£75.55 22 Oct 2026
Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs
77% match

Alternative and Complementary Therapies for Cancer: Integrative Approaches and Discovery of Conventional Drugs

Springer

£77.90 21 Oct 2026
Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)
77% match

Cytokines and Cancer: 126 (Cancer Treatment and Research, 126)

Springer

£113.76 23 Oct 2026
Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy
77% match

Drug Targeting Complexity: Tissue-Specific Regulation and Molecular Paradigms in Cancer Therapy

Elsevier

£135.76 22 Oct 2026
Systems Biology in Cancer Research and Drug Discovery
77% match

Systems Biology in Cancer Research and Drug Discovery

Springer

£113.39 22 Oct 2026
DNA Topoisomerases in Cancer Therapy: Present and Future
77% match

DNA Topoisomerases in Cancer Therapy: Present and Future

Springer

£85.85 12 Sep 2026
Enzyme-Prodrug Strategies for Cancer Therapy
77% match

Enzyme-Prodrug Strategies for Cancer Therapy

Springer

£149.87 23 Oct 2026
Fate and Effects of Anticancer Drugs in the Environment
77% match

Fate and Effects of Anticancer Drugs in the Environment

Springer

£104.76 17 Nov 2026